Skip To Content
When autocomplete results are available use up and down arrows to review and enter to select. Touch device users, explore by touch or with swipe gestures.
Before it's here, it's on the Bloomberg Terminal.
Learn More
TBET:USOTC US

Tibet Pharmaceuticals Inc

COMPANY INFO
Open
--
Prev Close
0.00
Volume
300
Market Cap
--
1D1M1Y5Y
View Full Chart
No pricing data is available for this time frame
1D1M1Y5Y
View Full Chart
No pricing data is available for this time frame
markets
Walmart Jumps Most in a Year on Strong 2Q Sales
Before it's here, it's on the Bloomberg Terminal.
Learn More
When autocomplete results are available use up and down arrows to review and enter to select. Touch device users, explore by touch or with swipe gestures.

Key Statistics

P/E Ratio--
Bloomberg (BEst) P/E Ratio--
Bloomberg (BEst) PEG Ratio--
Shares Outstanding14.85M
Price to Book Ratio--
Price to Sales Ratio--
1 Year Return-99.80%
30 Day Avg Volume193
EPS0.80
Bloomberg (BEst) EPS Curr Yr--
Dividend--
Last Dividend Reported--

About Tibet Pharmaceuticals Inc

Tibet Pharmaceuticals Inc. is a pharmaceutical company which researches, develops, manufactures, and markets modernized traditional Tibetan medicines.
Address
90 Jaffe Road Room 1701, 17/F Wan Chai Hong Kong (SAR)
Phone
852-9798-5569
Website
www.tibetpharmaceuticals.com

Board Members

Name/Company
View More
View More

Income Statement

Quarterly
Annual
Sorry, no quarterly data is available at this time.
Q3 2011 (Millions USD)
  • Revenue
    --
  • Net Income
    --
  • Profit Margin
    --%

Balance Sheet

Quarterly
Annual
Sorry, no quarterly data is available at this time.
Q3 2011 (Millions USD)
  • Total Assets
    --
  • Total Liabilities
    --
  • Debt to Assets
    --%

Cash Flow

Quarterly
Annual
Sorry, no quarterly data is available at this time.
Q3 2011 (Millions USD)
  • Operating
    --
  • Investing
    --
  • Financing
    --